WHY WORK FOR US? We are mission and values driven and your contributions will make a difference. We make a positive difference in peoples lives and help an average of 23 people per week to find
WHY WORK FOR US? We are mission and values driven and your contributions will make a difference. We make a positive difference in peoples lives and help an average of 23 people per week to find
Overview Entegral is seeking a motivated, adaptable, career-minded teammate who would like to utilize their skill set in a thriving agile-methodology environment. We offer competitive career advancement opportunities, a comprehensive benefits package and promote a work-life
The Role: Moderna Services, Inc. seeks a Sr. Manager, Clinical Data Management for its Cambridge, Massachusetts location. Here’s What You’ll Do: Lead data management activities for in-house and outsourced studies. Responsible for vendor oversight activities across
Job Description: Senior Accountant, Brokerage Accounting and Controllerhip Note: Fidelity will not provide immigration sponsorship for this position. The Role The Senior Accountant on the Brokerage Corporate Accounting Team is a key member of the
WHY WORK FOR US? We are mission and values driven and your contributions will make a difference. We make a positive difference in peoples lives and help an average of 23 people per week to find
Overview The Reimbursement Manager ensures compliance with regulations related to governmental and commercial reimbursement programs and works to mitigate the risk of loss of income and seize opportunities to provide value throughout the reimbursement process. This includes
What Youll Do: As the lead Biostatistician on the studies assigned, perform the following tasks: Act as primary statistical contact for internal and external project team members. Communicate and work with Biostatistics management to maintain the
Company Overview At Aditum Bio, our mission is to rapidly translate scientific discoveries into new medicines. Co-founded by industry veterans Joe Jimenez, former CEO of Novartis and Mark Fishman, former President of the Novartis Institutes for